These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 17031857)

  • 21. AMP-activated protein kinase inhibitor decreases prostaglandin F2α-stimulated interleukin-6 synthesis through p38 MAP kinase in osteoblasts.
    Kondo A; Otsuka T; Kato K; Natsume H; Kuroyanagi G; Mizutani J; Ito Y; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Int J Mol Med; 2012 Dec; 30(6):1487-92. PubMed ID: 23064268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells.
    Chen C; Shen G; Hebbar V; Hu R; Owuor ED; Kong AN
    Carcinogenesis; 2003 Aug; 24(8):1369-78. PubMed ID: 12819184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification by (‑)‑epigallocatechin gallate of prostaglandin F2α‑stimulated synthesis of osteoprotegerin in osteoblasts.
    Sakai G; Otsuka T; Fujita K; Kainuma S; Kuroyanagi G; Kawabata T; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Mol Med Rep; 2017 Nov; 16(5):6376-6381. PubMed ID: 28849144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (-)-Epigallocatechin gallate inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
    Kato K; Otsuka T; Adachi S; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
    Mol Med Rep; 2011; 4(2):297-300. PubMed ID: 21468567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of SAPK/JNK in basic fibroblast growth factor-induced vascular endothelial growth factor release in osteoblasts.
    Tokuda H; Hirade K; Wang X; Oiso Y; Kozawa O
    J Endocrinol; 2003 Apr; 177(1):101-7. PubMed ID: 12697041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK.
    Takai S; Matsushima-Nishiwaki R; Adachi S; Natsume H; Minamitani C; Mizutani J; Otsuka T; Tokuda H; Kozawa O
    Mediators Inflamm; 2008; 2008():291808. PubMed ID: 19148296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
    Kim M; Murakami A; Kawabata K; Ohigashi H
    Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) in prostaglandin F2alpha-induced heat shock protein 27 in osteoblasts.
    Tokuda H; Niwa M; Ishisaki A; Nakajima K; Ito H; Kato K; Kozawa O
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):441-7. PubMed ID: 15062846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells.
    Lee CC; Chen SC; Tsai SC; Wang BW; Liu YC; Lee HM; Shyu KG
    J Biomed Sci; 2006 Jan; 13(1):143-56. PubMed ID: 16328781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc suppresses IL-6 synthesis by prostaglandin F2alpha in osteoblasts: inhibition of phospholipase C and phospholipase D.
    Hatakeyama D; Kozawa O; Otsuka T; Shibata T; Uematsu T
    J Cell Biochem; 2002; 85(3):621-8. PubMed ID: 11968002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate.
    Katiyar SK; Afaq F; Azizuddin K; Mukhtar H
    Toxicol Appl Pharmacol; 2001 Oct; 176(2):110-7. PubMed ID: 11601887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SAPK/JNK plays a role in transforming growth factor-beta-induced VEGF synthesis in osteoblasts.
    Kanno Y; Ishisaki A; Yoshida M; Tokuda H; Numata O; Kozawa O
    Horm Metab Res; 2005 Mar; 37(3):140-5. PubMed ID: 15824967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of p38 mitogen-activated protein kinase mediates thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
    Ishisaki A; Tokuda H; Yoshida M; Hirade K; Kunieda K; Hatakeyama D; Shibata T; Kozawa O
    Mol Cell Endocrinol; 2004 Feb; 214(1-2):189-95. PubMed ID: 15062557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress-activated protein kinase/c-Jun N-terminal kinase (JNK) plays a part in endothelin-1-induced vascular endothelial growth factor synthesis in osteoblasts.
    Wang X; Tokuda H; Hirade K; Kozawa O
    J Cell Biochem; 2002; 87(4):417-23. PubMed ID: 12397601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPAR-gamma ligands up-regulate basic fibroblast growth factor-induced VEGF release through amplifying SAPK/JNK activation in osteoblasts.
    Yasuda E; Tokuda H; Ishisaki A; Hirade K; Kanno Y; Hanai Y; Nakamura N; Noda T; Katagiri Y; Kozawa O
    Biochem Biophys Res Commun; 2005 Mar; 328(1):137-43. PubMed ID: 15670761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin-dependent activation of ERK mediates cell proliferation induced by transforming growth factor beta in mouse osteoblastic cells.
    Ghayor C; Rey A; Caverzasio J
    Bone; 2005 Jan; 36(1):93-100. PubMed ID: 15664007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rho-kinase limits FGF-2-stimulated VEGF release in osteoblasts.
    Natsume H; Tokuda H; Adachi S; Takai S; Matsushima-Nishiwaki R; Kato K; Minamitani C; Niida S; Mizutani J; Kozawa O; Otsuka T
    Bone; 2010 Apr; 46(4):1068-74. PubMed ID: 20114091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase.
    Yamamoto N; Otsuka T; Kuroyanagi G; Kondo A; Kainuma S; Nakakami A; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Prostaglandins Other Lipid Mediat; 2015; 116-117():57-63. PubMed ID: 25677506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of Rho-kinase in prostaglandin E(1)-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblast-like MC3T3-E1 cells.
    Adachi S; Tokuda H; Matsushima-Nishiwaki R; Kato K; Natsume H; Minamitani C; Mizutani J; Otsuka T; Kozawa O
    Prostaglandins Other Lipid Mediat; 2009 Nov; 90(1-2):1-6. PubMed ID: 19524699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rho-kinase inhibitors decrease TGF-beta-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Kuno M; Takai S; Matsushima-Nishiwaki R; Minamitani C; Mizutani J; Otsuka T; Harada A; Adachi S; Kozawa O; Tokuda H
    Biochem Pharmacol; 2009 Jan; 77(2):196-203. PubMed ID: 18996357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.